SCHEMBL13289277

SCHEMBL13289277

Bc1cnn2c(NCCNC(=O)C3CCC(=O)N3)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.42

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 4/20 0.42
▸ GSK3B P49841 4/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ABL1 P00519 7/20 0.36
▸ CDK9 P50750 2/20 0.35
▸ HPGDS O60760 1/20 0.34
▸ VCP P55072 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13120275 0.90 CDK2 (0.54) CDK2GSK3BSMN1; SMN2MEN1KMT2A
SCHEMBL13288778 0.90 CDK2 (0.49) CDK2GSK3BSMN1; SMN2MEN1KMT2A
SCHEMBL13288867 0.87 CDK2 (0.47) CDK2GSK3BABL1VCP
SCHEMBL13120066 0.86 CDK2 (0.52) CDK2GSK3BSMN1; SMN2MEN1KMT2A
SCHEMBL14545262 0.85 CDK2 (0.45) CDK2GSK3BSMN1; SMN2MEN1KMT2A
SCHEMBL13288877 0.83 CDK2 (0.45) CDK2GSK3BABL1
SCHEMBL12954447 0.82 CDK2 (0.46) CDK2GSK3BABL1VCP
SCHEMBL13288683 0.82 CDK2 (0.46) CDK2GSK3BABL1VCP
SCHEMBL14613481 0.82 SMN1; SMN2 (0.42) CDK2GSK3BSMN1; SMN2MEN1KMT2A
SCHEMBL13288970 0.81 CDK2 (0.45) CDK2GSK3BABL1VCP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194058-A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases SCHERING CORPORATION (US) 2010-06-09 — — EP disclosed
Send feedback